Abstract
SARS-CoV-2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have